TY - JOUR
T1 - New alkylresorcinol metabolites in spot urine as biomarkers of whole grain wheat and rye intake in a Swedish middle-aged population
AU - Landberg, Rikard
AU - Wierzbicka, Roksana
AU - Shi, Lin
AU - Nybacka, Sanna
AU - Kamal-Eldin, Afaf
AU - Hedblad, Bo
AU - Lindroos, Anna Karin
AU - Winkvist, Anna
AU - Forslund, Heléne Bertéus
N1 - Funding Information:
Acknowledgements We would like to thank Ms Janicka Nilsson for excellent technical assistance with the analysis of alkylresorcinol metabolites. Collection of data and samples for the present study was supported by Region Skåne and Albert Påhlsson Research Foundation. SCAPIS is supported by the Swedish Heart and Lung Foundation, the Knut and Alice Wallenberg Foundation, the Swedish Research Council and VINNOVA. The SCAPIS pilot study was supported by funding from Sahlgrenska Academy at Gothenburg University and strategic grants from ALF/LUA in Western Sweden. Analysis of alkylresorcinol metabolites was supported by grants from Formas and VR-medicine. No funder had any role in the design, analysis or writing of this article.
Publisher Copyright:
© 2018, Macmillan Publishers Limited, part of Springer Nature.
PY - 2018/10/1
Y1 - 2018/10/1
N2 - Background/objectives: Studies on the health effects of whole grains typically use self-reported intakes which are prone to large measurement errors. Dietary biomarkers that can provide an objective measure of intake are needed. New alkylresorcinol (AR) metabolites (3,5-dihydroxycinnamic acid (DHCA), 2-(3,5-dihydroxybenzamido)acetic acid (DHBA-glycine) and 5-(3,5-dihydroxyphenyl) pentanoic acid (DHPPTA)) in 24 h urine samples have been suggested as biomarkers for whole grain (WG) wheat and rye intake but remain to be evaluated in spot urine samples. Subjects/methods: The reproducibility of the new AR metabolites (DHCA, DHBA-glycine and DHPPTA) was investigated in 4 repeated samples over a period of 2 wk in spot urine from 40 Swedish men and women enroled in the SCAPIS-study, after adjustment of creatinine. Metabolite concentrations were correlated with total whole grain intake estimated during the same period. Results: The medium-term reproducibility determined for DHCA, DHPPTA and DHBA-glycine varied from moderate to excellent (intra-class correlation coefficient = 0.35–0.67). Moreover, DHCA and DHBA-glycine were independently associated with self-reported total WG intake (β = 0.18, P = 0.08 and β = 0.18, P = 0.02, respectively) and all metabolites except for DHPPA were higher among women. Conclusions: This study supports the idea of using AR metabolites in one or several spot urine samples as biomarkers of whole grain intake. These findings need to be confirmed in different populations.
AB - Background/objectives: Studies on the health effects of whole grains typically use self-reported intakes which are prone to large measurement errors. Dietary biomarkers that can provide an objective measure of intake are needed. New alkylresorcinol (AR) metabolites (3,5-dihydroxycinnamic acid (DHCA), 2-(3,5-dihydroxybenzamido)acetic acid (DHBA-glycine) and 5-(3,5-dihydroxyphenyl) pentanoic acid (DHPPTA)) in 24 h urine samples have been suggested as biomarkers for whole grain (WG) wheat and rye intake but remain to be evaluated in spot urine samples. Subjects/methods: The reproducibility of the new AR metabolites (DHCA, DHBA-glycine and DHPPTA) was investigated in 4 repeated samples over a period of 2 wk in spot urine from 40 Swedish men and women enroled in the SCAPIS-study, after adjustment of creatinine. Metabolite concentrations were correlated with total whole grain intake estimated during the same period. Results: The medium-term reproducibility determined for DHCA, DHPPTA and DHBA-glycine varied from moderate to excellent (intra-class correlation coefficient = 0.35–0.67). Moreover, DHCA and DHBA-glycine were independently associated with self-reported total WG intake (β = 0.18, P = 0.08 and β = 0.18, P = 0.02, respectively) and all metabolites except for DHPPA were higher among women. Conclusions: This study supports the idea of using AR metabolites in one or several spot urine samples as biomarkers of whole grain intake. These findings need to be confirmed in different populations.
UR - http://www.scopus.com/inward/record.url?scp=85040670236&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040670236&partnerID=8YFLogxK
U2 - 10.1038/s41430-017-0079-5
DO - 10.1038/s41430-017-0079-5
M3 - Article
C2 - 29352219
AN - SCOPUS:85040670236
SN - 0954-3007
VL - 72
SP - 1439
EP - 1446
JO - European Journal of Clinical Nutrition
JF - European Journal of Clinical Nutrition
IS - 10
ER -